O2h Wins Erbi Award - Innovation in Enabling Biotechnology

Thursday, December 18, 2008 General News
Email Print This Page Comment
Font : A-A+

CAMBRIDGE, England, December 18 ERBI's Innovation inEnabling Bio-Technology Award 2008 was presented to Oxygen Healthcare Ltd(O2h) at the ERBI Winter Ball held at Duxford's Imperial War Museum. Thisaward recognises the role O2h has played in developing technologies thatfacilitate drug discovery and development.

"To receive recognition for innovation from an organisation that hoststhe largest bio cluster in Europe makes us extremely proud," said Sunil Shah,CEO and Head of Business Development who accepted this award from LadyArcher. "O2h was incorporated in 2003 and we have grown the companyorganically as owner-entrepreneurs from business plan," he added.

O2h, founded by brothers Prashant and Sunil Shah, is a 4+ year old,discovery services company. Its 90 employees work from a client projectoffice in Cambridge, UK and its operations in Ahmedabad India. The currentclients of O2h include several top 20 pharmaceutical and biotechnologycompanies in the US, Europe and Japan. The Indian operation enables O2h toprovide a high level of discovery expertise while its UK office providesproject management support. O2h has set a target of becoming the 'BestPerforming Discovery Services Company in the World' and has therefore set foritself the highest standards of performance with a particular emphasis onrapid interactive communications and delivery speed. The services includeFTE-based synthetic chemistry, Medicinal Chemistry, Computational Chemistry,Full services lab-units and ADME.

Commenting on the award, Prashant Shah, co-founder and COO of OxygenHealthcare said: "I am delighted that O2h has won this award, it is arecognition that drug discovery has become truly global and of the hard workthe team has put into ensuring fast results for our collaborations."

Contact: Ekta Ahuja, email: info@oxygenhealthcare.com, Tel:+91-2717-250262 / 63 / 64

SOURCE Oxygen Healthcare Ltd (O2h)


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook